Details of Disease

General Information of Disease (ID: DIS5KXQB)

• Disease Name: Horner syndrome
• Synonyms: oculosympathetic palsy; Bernard-Horner syndrome; cervical sympathetic paralysis; Horner's syndrome; Horner syndrome; Bernard Horner syndrome
• Disease Class: 8D8A: Focal/segmental autonomic disorder
• Definition: Horner's syndrome is a rare condition characterized by miosis (constriction of thepupil), ptosis (drooping of the upper eyelid), and anhidrosis (absence of sweating of the face). It iscaused by damage to the sympathetic nerves of the face. The underlying causes of Horner's syndrome vary greatly and may include a tumor, stroke, or other damage to a part of the brain called the brain stem ; injury to the carotid artery ;and trauma to the brachial plexus. In rare cases, Horner's syndrome is congenital (present from birth) and associated with a lack of pigmentation of the iris (colored part of the eye). Treatment of Horner's syndrome depends on the underlying cause.
• Disease Hierarchy:
  DISI3WJ0: Autonomic neuropathy
  DIS5KXQB: Horner syndrome
• ICD Code:
  ICD-11: ICD-11: 8D8A.1
  ICD-10: ICD-10: G90.2
• Disease Identifiers:
  MONDO ID: MONDO_0001294
  MESH ID: D006732
  UMLS CUI: C0019937
  MedGen ID: 5616
  HPO ID: HP:0002277
  SNOMED CT ID: 1281810006

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Hydroxyamphetamine Hydrobromide	DMQSGM0	Approved	Small molecular drug	[1]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015